Increased expression of in situ IL‐31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL‐31 family in the pathogenesis of the disease. (7th July 2020)
- Record Type:
- Journal Article
- Title:
- Increased expression of in situ IL‐31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL‐31 family in the pathogenesis of the disease. (7th July 2020)
- Main Title:
- Increased expression of in situ IL‐31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL‐31 family in the pathogenesis of the disease
- Authors:
- Morais, K.L.
Miyamoto, D.
Orfali, R.L.
Maruta, C.W.
Santi, C.G.
Sotto, M.N.
da Silva, L.F.F.
Branco, A.C.C.C
Sato, M.N.
Aoki, V. - Abstract:
- Abstract: Background: Pemphigus herpetiformis (PH) is a rare clinical subtype of pemphigus with the presence of urticarial plaques, severe pruritus, rare acantholysis and eosinophilic spongiosis. Objectives: The aim of this study was to investigate the influence of IL‐31 and pro‐inflammatory cytokines/chemokines in the pathogenesis of PH. Methods: Twenty‐five patients with PH and three groups: pemphigus foliaceus (PF = 14), pemphigus vulgaris (PV = 15) and healthy controls (HC = 20) were selected for this study. The groups were analysed by immunohistochemistry utilizing IL‐31, IL‐31RA, IL‐4, IL‐17 and TNF‐α antibodies. Serum levels of IL‐4, IL‐13, TNF, CXCL8, CCL5 and CCL2 were evaluated by cytometric bead array. Results: Analysis of IL‐31 family of PH patients revealed the following findings: (i) Enhanced in situ expression of IL‐31 in PH samples, compared to PF and to PV (epidermis); (ii) Cutaneous IL‐31RA expression in PH samples was higher than in PF, PV and HC groups (epidermis and dermis); (iii) PF patients that evolved to PH showed significant increased IL‐31RA epidermal expression during the PH phase. Profile of pro‐inflammatory cytokines (IL‐4, IL‐17 and TNF‐α) in PH patients' skin exhibited: (i) Enhanced IL‐4 expression, when compared to patients with PF (epidermis and dermis) and with PV (epidermis); (ii) Augmented IL‐17 expression than PF and PV patients (epidermis); (iii) Augmented expression of TNF‐α when compared to PF at the epidermal level. Evaluation ofAbstract: Background: Pemphigus herpetiformis (PH) is a rare clinical subtype of pemphigus with the presence of urticarial plaques, severe pruritus, rare acantholysis and eosinophilic spongiosis. Objectives: The aim of this study was to investigate the influence of IL‐31 and pro‐inflammatory cytokines/chemokines in the pathogenesis of PH. Methods: Twenty‐five patients with PH and three groups: pemphigus foliaceus (PF = 14), pemphigus vulgaris (PV = 15) and healthy controls (HC = 20) were selected for this study. The groups were analysed by immunohistochemistry utilizing IL‐31, IL‐31RA, IL‐4, IL‐17 and TNF‐α antibodies. Serum levels of IL‐4, IL‐13, TNF, CXCL8, CCL5 and CCL2 were evaluated by cytometric bead array. Results: Analysis of IL‐31 family of PH patients revealed the following findings: (i) Enhanced in situ expression of IL‐31 in PH samples, compared to PF and to PV (epidermis); (ii) Cutaneous IL‐31RA expression in PH samples was higher than in PF, PV and HC groups (epidermis and dermis); (iii) PF patients that evolved to PH showed significant increased IL‐31RA epidermal expression during the PH phase. Profile of pro‐inflammatory cytokines (IL‐4, IL‐17 and TNF‐α) in PH patients' skin exhibited: (i) Enhanced IL‐4 expression, when compared to patients with PF (epidermis and dermis) and with PV (epidermis); (ii) Augmented IL‐17 expression than PF and PV patients (epidermis); (iii) Augmented expression of TNF‐α when compared to PF at the epidermal level. Evaluation of circulating cytokines and chemokines showed higher levels of CXCL8 and CCL2 in PH sera compared to HC group. Conclusions: IL‐31 and IL‐31RA, cytokines related to pruritus, and pro‐inflammatory chemokines (CXCL8 and CCL2) seem to exert a role in the pathogenesis of PH. These findings support future studies to clarify the role of IL‐31 pathway as a potential therapeutic target for patients with PH. … (more)
- Is Part Of:
- Journal of the European Academy of Dermatology and Venereology. Volume 34:Number 12(2020)
- Journal:
- Journal of the European Academy of Dermatology and Venereology
- Issue:
- Volume 34:Number 12(2020)
- Issue Display:
- Volume 34, Issue 12 (2020)
- Year:
- 2020
- Volume:
- 34
- Issue:
- 12
- Issue Sort Value:
- 2020-0034-0012-0000
- Page Start:
- 2890
- Page End:
- 2897
- Publication Date:
- 2020-07-07
- Subjects:
- Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗ - DOI:
- 10.1111/jdv.16730 ↗
- Languages:
- English
- ISSNs:
- 0926-9959
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23417.xml